Boston Scientific Announces Resumption of Distribution of Advanced Bionics Cochlear Auditory Implant
(November 8, 2004) -- Boston Scientific Corporation (NYSE: BSX) today announced that its subsidiary, Advanced Bionics Corporation of Valencia, California, is resuming worldwide distribution of its HiResolution® cochlear implant systems, effective immediately. Advanced Bionics initiated a voluntary recall of all unimplanted cochlear implant systems on September 24, 2004.

Cochlear implants are used to treat adults with severe or profound bilateral hearing loss (70 decibel or greater) and children -- 12 months to 17 years -- with profound bilateral hearing loss (90 decibel or greater). More than 16,000 adults and children use Advanced Bionics cochlear implants, which produce an electrical reproduction of acoustic signals through proprietary HiResolution processing technology.

Boston Scientific acquired Advanced Bionics in June.

Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit:

This press release contains forward-looking statements. The Company wishes to caution the reader that actual results may differ from those discussed in the forward-looking statements and may be adversely affected by, among other things, risks associated with the regulatory process, litigation, competitive product offerings and other factors described in the Company's filings with the Securities and Exchange Commission.